Pareira (Chondrodendron tomentosum / Cissampelos pareira)
1. Identity, Botanical Classification, and Natural Source
The name Pareira — more fully Pareira brava (from the Portuguese meaning "wild pareira") — designates a medicinal root obtained primarily from Chondrodendron tomentosum Ruiz & Pavon, a large, woody climbing liana in the family Menispermaceae. Chondrodendron tomentosum is one of six accepted species in the small genus Chondrodendron, belonging to the Moonseed family Menispermaceae; it is a large tropical liana native to Central and South America. The plant is a woody climber with stems that can reach 10 cm in thickness at the base and which can climb up to 30 metres into the rainforest canopy.
The binomial carries a descriptive etymology: the generic name is a compound of Greek chondros ("cartilage / lump / grain") and dendron ("tree"), while the specific name consists of the Latin adjectival form tomentosum, meaning "covered in matted hairs." The binomial was formally established by Spanish botanists Hipólito Ruiz López and José Antonio Pavón y Jiménez in their 1798 publication Systema Vegetabilium Florae Peruvianae et Chilensis, based on specimens collected during their botanical expedition to the Viceroyalty of Peru from 1777 to 1788.
Synonyms recorded in historical pharmacopoeias and botanical literature include Cocculus Chondodendron De Candolle, Cissampelos Abutua Vellozo, and Botryopsis platyphylla Miers. The name "pareira" or "pareira brava" refers to the medicinal root and originated from South American trade names, while "velvet leaf" highlights the soft, hairy underside of the leaves. Additional common names include Virgin Vine, Ice Vine, Fleur de Velours, Parra Brava, and Curare Vine.
A closely related and historically confounded species is Cissampelos pareira L., also in the family Menispermaceae, which is widely distributed across tropical and subtropical Asia, Africa, and the Americas. Cissampelos pareira is a well-known Ayurvedic medicinal herb; it belongs to the family Menispermaceae and is known as ambastha or laghupatha in Indian traditional medicine. In some countries it is a permitted substitute for Chondrodendron tomentosum from South America in the drug "pareira brava." In pharmacognostic and ethnobotanical literature these two plants are frequently discussed together under the name "pareira," as they share overlapping chemistry, medicinal uses, and geographic distribution within the Menispermaceae family.
Morphology of the Official Drug
C. tomentosum is a climbing plant with a stout woody stem growing to a considerable height; it is a native of Peru and Brazil, and is regarded by the Brazilians as a valuable medicine. It is a climbing, woody vine, remarkable for the size of its leaves — about a foot long, broadly ovate or rounded, slightly cordate, with a smooth upper surface and on the under surface covered with a fine close wool of an ashy hue. The racemose fruits are of the size of large grapes, oval and black.
The official drug part is the dried root. True pareira brava occurs in long, woody, nearly cylindrical pieces averaging 2 to 4 cm in diameter but attaining 5 cm or even more. It is nearly black in colour, tortuous and knotty, and marked externally with longitudinal furrows and transverse ridges and fissures. It is hard and heavy, breaking with a coarsely fibrous fracture; internally it is yellowish or brownish grey.
Pharmacopoeial Status
Pareira was formerly official in the U.S. Pharmacopoeia (U.S.P. VIII) and the British Pharmacopoeia (Br.). The British Pharmacopoeia described the official drug as "the dried roots of Chondrodendron tomentosum Ruiz and Pavon (Fam. Menispermaceae) without the presence of more than 5 per cent. of stems or other foreign matter." The drug has since been dropped from both major pharmacopoeias, though it retained entry in the United States National Formulary (N.F. IV) for a period.
2. Traditional and Historical Use
Indigenous South American Use: Curare Arrow Poison
The most consequential traditional use of Chondrodendron tomentosum is the preparation of curare, a paralytic arrow poison used by Amazonian indigenous peoples for hunting. Many different plants are used to prepare curare arrow poisons and many different recipes are used by different Indian tribes in the Amazon. Tribes in Peru, Ecuador and Brazil use curare vine (Chondrodendron tomentosum). In both cases it is usually a combination of several different plants, and sometimes even snake and frog venom is added. The Sionas of Colombia, the Lamistas of Peru, and the Ketchwa of Ecuador use curare vine in the preparation of their poisons, crushing and cooking the stems and roots of the vine and adding other plants and venomous animals.
From the time of Columbus's voyages, exaggerated tales abound about the powers of the native South American weapon poisons; such tales are given in the writings of 16th, 17th, and 18th century explorers, including Sir Walter Raleigh. Pareira has long been used by local people both to make a poison used in hunting and also as a healing herb.
Crucially, curare had been used as a source of arrow poison by South American natives to hunt animals, and they were able to eat the animals' contaminated flesh subsequently without any adverse effects because tubocurarine cannot easily cross mucous membranes; tubocurarine is therefore effective only if given parenterally.
South American Traditional Medicine
Beyond its use as a poison, pareira has long been used by local people as a healing herb. Traditional South American healers used the root as a diuretic and to promote urinary flow. Pareira has a history of use in traditional herbal medicine, especially in South America, for urinary tract issues including kidney infections; its primary use is as a diuretic and to promote urinary flow, with traditional healers recommending it for various urinary complaints such as cystitis, nephritis, and kidney stones.
Introduction to European Medicine
Infusion of pareira brava (Chondrodendron tomentosum), a wild vine native to Peru and Brazil, is said to have been brought back to Paris by Michel-Jean Amelot (1655–1724), Louis XIV's ambassador in Lisbon. This event marked the introduction of the plant into European pharmacopoeial interest. It was subsequently listed in both the British and American Pharmacopoeias, where it was employed for urinary complaints.
In eclectic medical practice (19th century North America), this remedy was valued in the treatment of chronic diseases of the kidneys or bladder where the urine was scanty and contained large quantities of earthy salts or urates. Where with these irritating substances there was ulceration of the kidneys or bladder, irritation, frequent desire to urinate, and pain in the organs during urination were reported to be relieved by this remedy.
Ayurvedic and Indian Traditional Medicine (Cissampelos pareira)
Cissampelos pareira has a long history of use in Ayurveda, Siddha, and folk medicine. Traditionally known as the "midwife's herb" in Ayurveda, it has been employed to manage female reproductive health, gastrointestinal disorders, inflammatory diseases, and urinary conditions. In Ayurvedic classification, Cissampelos pareira is known as laghupatha, whilst Cyclea peltata is known as rajpatha, and they are apparently used interchangeably as two species known as "patha" in Ayurvedic medicine.
In the Ayurvedic system of medicine, the leaves and roots are used in the treatment of indolent ulcers and diarrhea. The plant is used in the treatment of urinary tract infections since it is considered antiseptic. Juice of C. pareira is given in migraine, and the plant has a long history of use for inflammation of muscles, snakebite, rheumatism, diarrhoea, dysentery and menstrual problems.
Traditional Uses Across Cultures
Species of Cissampelos (Menispermaceae) are widely used in folk medicine in various cultures for the treatment of a wide variety of diseases. Several ethnobotanical studies have reported the use of these species, which, among other benefits, instigated further research on several pharmacological properties and biologically active compounds. Various parts of the plant, including roots, leaves, and aerial parts, are employed to address urinary problems, skin infections, gastrointestinal issues, respiratory conditions, and reproductive disorders. It is used as an astringent, antispasmodic, analgesic, antipyretic, diuretic, antilithic, and emmenagogue.
Homeopathic Use
In the homeopathic tradition, pareira brava was adopted based on its documented traditional uses in urinary complaints. In homeopathic materia medica (Boericke), pareira brava's urinary symptoms are regarded as most important, useful in renal colic, prostatic affections, and catarrh of bladder, with a sensation as if the bladder were distended with pain going down the thigh. As a homeopathic product, it has not been evaluated by the Food and Drug Administration for safety or efficacy; the FDA is not aware of scientific evidence to support homeopathy as effective.
3. Key Constituents and Active Compounds
Alkaloid Profile of Chondrodendron tomentosum
Chondrodendron tomentosum contains highly toxic alkaloids and is one of the sources of the arrow poison curare — specifically "tube curare," the name of which is derived from the medicinally valuable alkaloid tubocurarine. Curare is a plant extract obtained from Strychnos toxifera, Chondrodendron tomentosum, and related species indigenous to South America; the principal active constituent is (+)-tubocurarine (d-Tubocurarine).
Tubocurarine chloride (as d-tubocurarine chloride), isolated from the bark and stems of the South American vine Chondrodendron tomentosum, was the form initially used in medicine. In Oxford, in 1935, King examined the constituents of museum specimens and was able to identify and characterise the first samples of (+)-tubocurarine (still called d-tubocurarine in the USA).
Early pharmacognostic analyses of the root also identified other alkaloids. Wiggers announced in 1838 the existence in pareira brava of an alkaloid, for which he proposed the name of pelosine or cissampeline. Flückiger (1870) found an alkaloid in pareira and, having thoroughly determined its origin and properties, fixed its composition at C₁₈H₂₁NO₃, showing its identity with the bebeerine of nectandra and the buxine of Buxus sempervirens. The root contains alkaloidal matter, of which about 10 per cent. consists of beberine, formerly called pelosine; an amorphous alkaloid named chondrodine is also present. The drug is remarkable for the large quantity of free fatty acids (about 9 per cent.), chiefly stearic acid.
Alkaloid Profile of Cissampelos pareira
Phytochemically, benzylisoquinolines and bisbenzylisoquinolines are the major classes of alkaloids reported from this plant. In silico molecular docking has revealed prominent interactions of bisbenzylisoquinolines such as hayatinine and curine with key antimalarial enzyme targets.
Its long roots are rich in alkaloidal contents such as pelosine, hayatine, hayatinine, hayatidine, cissampareine, tetrandrine, cycleanine, insularine, sepeerine, homoaromoline, magnocurarine, coclaurine, pareirarine, dicentrine, dehydrodicentrine, magnoflorine, pareirubrines, isoimerubrine, grandirubrine, pareitropone, cissamine, berberine, norimeluteine and norruffscine. Besides these alkaloids, other non-alkaloidal constituents such as fatty acids (like oleic acid and arachidic acid), flavonoids (like quercetin), and terpenoids (like oleanolic acid and thymol) were also reported from the roots of C. pareira.
To date, approximately 54 phytomolecules have been isolated and characterized from C. pareira including mainly isoquinoline alkaloids along with a few flavonoids, flavonoid glycosides, and fatty acids. A 2017 phytochemical study confirmed the isolation of one new isoquinoline alkaloid along with six known isoquinoline alkaloids from Cissampelos pareira: magnoflorine, magnocurarine, cissamine, curine, hayatinine, and cycleanine. Magnoflorine and magnocurarine were isolated for the first time from C. pareira in that work.
Antitumour potential of cissampareine and neuromuscular blocking effects of hayatine are of special interest among these constituents. Many alkaloids isolated from Cissampelos such as warifteine, methylwarifteine, berberine, hayatin, and hayatidin showed promising anti-allergic, immunosuppressive, antidepressant, anticancer, vasodilatory, and muscle-relaxant activities.
4. Mechanisms of Action
Tubocurarine and Neuromuscular Blockade
The best-characterized mechanism of action for any constituent of pareira involves d-tubocurarine from C. tomentosum. d-Tubocurarine is present in substantial quantities in Amazonian Chondrodendron tomentosum alongside several other alkaloids. It acts as a competitive antagonist at muscle-type nicotinic acetylcholine receptors, preventing acetylcholine from binding and activating the receptor-channel complex. This competitive antagonism leads to a decrease in the amplitude of end-plate potentials and a reduction in the frequency of single-channel currents, resulting in muscle paralysis. Reversal of paralysis may be hastened via the administration of cholinesterase inhibitors, prolonging the availability of naturally produced acetylcholine.
Crucially for oral herbal use, the alkaloids responsible for the muscle relaxant effect are not absorbed by the digestive tract and have to be administered intravenously. Pareira contains tubocurarine, an ingredient in modern intravenous (IV) anesthetics used to block nerve signals and paralyze muscles; however, very little, if any, of the tubocurarine in pareira gets absorbed into the body when taken by mouth.
Anti-inflammatory and Analgesic Mechanisms
The plant exhibits strong anti-inflammatory and analgesic effects through the inhibition of inflammatory mediators, supported by bioactive alkaloids such as berberine and isoliensinine. In 1962, researchers reported that pareira (Cissampelos pareira) demonstrated anti-inflammatory, smooth muscle relaxant, antispasmodic, and uterine relaxant actions in various laboratory animals. Subsequent studies with animals confirmed the plant's antispasmodic and anti-inflammatory actions in several studies.
Antimalarial Mechanisms
Phytochemically, benzylisoquinolines and bisbenzylisoquinolines are the major classes of alkaloids associated with antimalarial properties. In silico molecular docking revealed prominent interactions of bisbenzylisoquinolines such as hayatinine and curine with Pfdihydrofolate reductase (−6.983 Kcal/mol and −6.237 Kcal/mol), PfcGMP-dependent protein kinase (−6.652 Kcal/mol and −7.158 Kcal/mol), and Pfprolyl-tRNA synthetase (−7.569 Kcal/mol and −7.122 Kcal/mol).
5. Scientific Evidence by Area of Use
5.1 Neuromuscular Blockade (d-Tubocurarine from C. tomentosum)
This represents the area with the strongest and most robust scientific evidence, though the active agent is not used in oral herbal preparations. Descriptions of South American arrow poisons known as curares were reported by explorers in the 16th century, and their site of action in producing neuromuscular block was determined by Claude Bernard in the mid-19th century. Tubocurarine, the most important curare alkaloid, played a large part in experiments to determine the role of acetylcholine in neuromuscular transmission, but it was not until after 1943 that neuromuscular blocking drugs became established as muscle relaxants for use during surgical anaesthesia. In the middle of the last century, d-TC was a popular choice in surgery, although there were some adverse effects on blood pressure and the cardiovascular system.
Evidence strength: Very strong for the isolated pharmaceutical compound d-tubocurarine administered parenterally. This is well-established pharmacology and clinical medicine. It is entirely irrelevant to oral ingestion of the herbal root preparation, from which tubocurarine is not absorbed.
5.2 Urinary / Diuretic Activity
In ethno-medicinal practices, the roots of Cissampelos pareira (patha) are used in the treatment of various ailments related to urinary problems and skin infections, and in tumor inhibitor activity, antibacterial, antimalarial, and diuretic activity.
Several animal studies have investigated diuretic activity of the root extract. One study evaluated the diuretic activity of aqueous extract of roots of Cissampelos pareira (AQERCP) by the Lipschitz method in albino rats, with groups treated with 100 mg/kg, 200 mg/kg, and 400 mg/kg of extract. A separate study using alcoholic extract found that single dose administration of alcoholic extract of roots of Cissampelos pareira significantly (p < 0.05) increased urine output along with an increase in elimination of sodium, potassium, and chloride ions; alcoholic extract of roots at 400 mg/kg produced a comparable diuretic activity with standard furosemide.
Evidence strength: Preclinical only (animal models). There is no good scientific evidence to support any use in humans. No controlled clinical trials in human populations have been identified in the peer-reviewed literature for this indication.
5.3 Antimalarial Activity
Among several herbs, Cissampelos pareira is a well-known Ayurvedic medicinal herb, and its leaf juice is used to treat malarial fever. Laboratory investigations have examined this traditional use rigorously. Among different extracts, the hydro-ethanolic extract of root of C. pareira was found most active against Plasmodium falciparum with IC₅₀ values of 1.42 and 1.15 μg/ml against Pf 3D7 and Pf INDO, respectively. The most potent fractions were root ethyl acetate fraction (IC₅₀ 4.0 μg/ml), stem water fraction (IC₅₀ 4.4 μg/ml), and root water fraction (IC₅₀ 8.5 μg/ml).
Phytochemical investigation of active fractions of the root led to the isolation and characterization of a new isoquinoline alkaloid, pareirarine (8), along with five known compounds including hayatinine (15). Hayatinine, a bisbenzylisoquinoline alkaloid, was the most promising compound with IC₅₀ of 0.41 μM (Pf INDO) and 0.509 μM (Pf 3D7). Magnocurarine and cissamine were also found active, with IC₅₀ values of 12.51 and 47.34 μM against Pf INDO and 12.54 and 8.76 μM against Pf 3D7, respectively.
Evidence strength: In vitro (cell culture) and in silico (molecular docking) only. No controlled human clinical trials have been identified. The results provide pharmacological rationale supporting traditional use but do not constitute clinical evidence of efficacy.
5.4 Anti-inflammatory and Antiarthritic Activity
Pharmacological activity including analgesic and antipyretic, anti-inflammatory, anti-allergic, bronchodilator, and immunomodulatory activity has been confirmed in vitro and/or in vivo for various Cissampelos species. A study published in the Journal of Ethnopharmacology (Amresh et al., 2007) evaluated antinociceptive and antiarthritic activity of Cissampelos pareira roots in animal models. The crude phytochemical extracts of different parts of C. pareira have been scientifically evaluated for anti-inflammatory (Amresh et al., 2007a), antiarthritic (Amresh et al., 2007b), antiulcer (Amresh et al., 2007c), immunomodulatory (Bafna and Mishra, 2010), and antipyretic (Singh et al., 2016b) activity.
Evidence strength: Preclinical (animal and in vitro). No human clinical trial data were identified.
5.5 Hepatoprotective Activity
Rats given a hydroalcoholic extract of Cissampelos pareira roots (CPRE) showed a strong hepatoprotective effect against CCl₄-induced hepatotoxicity. Rats treated with CPRE showed a substantial reduction in elevated blood marker enzymes including AST, ALT, ALP, and serum bilirubin to levels close to normal. The treatment groups treated with 100, 200, and 400 mg/kg of CPRE also showed a substantial reduction in lipid peroxidation levels. After receiving 200 and 400 mg/kg doses of CPRE, the levels of antioxidant enzymes SOD and catalase rose noticeably, and GST, GPx, and GSH levels also increased. These findings correlate with previously published reports of hepatoprotective activity (Indian J Exp Biol., Surendran et al., 2011).
Evidence strength: Preclinical (rodent models of chemically induced hepatotoxicity). No human clinical trial data were identified.
5.6 Anticancer / Cytotoxic Activity
The plant contains a number of alkaloids with medicinal activity, some of which have shown potent antileukemic activity. Several experiments on rhizome extracts have been carried out, and a water-ethanol extract of the rhizomes reduced the growth and multiplication rate of stomach tumours in a dose-dependent manner.
An in vivo study evaluated C. pareira against Dalton's Lymphoma Ascites (DLA) cells in Swiss mice. The in vivo study was carried out with methanol extract. Twenty-four hours after intraperitoneal inoculation of the DLA cells in mice, the methanol extract of C. pareira (MECP) was administered at 200 and 400 mg/kg body weight for 14 consecutive days. On day 14, six mice were sacrificed and the rest were kept alive for assessment of increase in life-span.
The chloroform and n-butanol fractions of C. pareira showed cytotoxic efficacy against KB cells. Among pure compounds, hayatinine was found to be most active against KB and A549 cell lines, while cycleanine was active against KB cells.
A 2025 PMC study examining antioxidant and anticancer activity of stem and leaf extracts found that ethanolic extracts of both stems and leaves showed notably high levels of total phenolic and flavonoid compounds. The total phenolic content was 58.26 ± 2.56 mg GAE/g dry weight in the stem extract and 95.73 ± 1.76 mg GAE/g in the leaf extract. The total flavonoid content was 27.23 ± 2.89 mg CE/g DW in stem extract and 82.68 ± 4.98 mg CE/g DW in leaf extract.
Evidence strength: Preclinical (cell lines and murine models). Antitumour potential of cissampareine has drawn scientific interest but no human clinical trials have been identified.
5.7 Antifertility and Reproductive Effects
C. pareira is used in folk medicine as an emmenagogue and has reported antifertility activity in preclinical studies. A study published in the Journal of Ethnopharmacology (Ganguly et al., 2007) investigated antifertility activity of methanolic leaf extract in female albino mice. The literature confirms antifertility activity has been established in vitro and/or in vivo for various Cissampelos species.
Evidence strength: Preclinical animal studies only. The emmenagogue/abortifacient effects documented in animal studies underpin the safety concerns regarding pregnancy (see Section 7).
5.8 Antimicrobial Activity
One study showed that methanolic leaf extracts of C. pareira inhibit the growth of E. coli, K. pneumoniae, S. typhi, and S. aureus (ZOIs = 7–8.5 mm) at a concentration of 10 µg/mL. Its antimicrobial and antivenom properties have reinforced its role in treating infections and snakebites.
Evidence strength: In vitro only. No controlled human studies were identified.
5.9 Cardiovascular and Immunomodulatory Activity
Cissampelos pareira is reported to have cardioprotective and immunomodulatory activity in preclinical studies, including a study examining the effect of C. pareira root extract on isoproterenol-induced cardiac dysfunction (Singh et al., 2013, J Nat Med). Many alkaloids isolated from Cissampelos such as warifteine, methylwarifteine, berberine, hayatin, and hayatidin showed promising vasodilatory and muscle-relaxant activities.
Evidence strength: Preclinical only. No human studies were identified for these specific indications.
6. Body Systems and Health Areas Associated with Pareira
- Urinary system: Historically the primary medicinal target — diuresis, kidney stones, cystitis, urinary retention, renal colic, and urethritis. Evidence: traditional/historical and preclinical animal only.
- Neuromuscular system: The isolated alkaloid d-tubocurarine is a landmark pharmaceutical neuromuscular blocking agent used in anaesthesia. Evidence: very strong for the isolated IV-administered compound; irrelevant to oral herbal use.
- Infectious / parasitic disease: Traditional use for malaria supported by in vitro antiplasmodial activity of isolated alkaloids. Antimicrobial activity against bacterial pathogens demonstrated in vitro.
- Musculoskeletal / inflammatory: Preclinical anti-inflammatory and antiarthritic evidence in animal models.
- Liver / hepatic: Hepatoprotective activity against chemically induced hepatotoxicity in rodent models.
- Oncology: Cytotoxic and antitumour activity against cancer cell lines and murine tumour models.
- Reproductive system: Traditional emmenagogue use; antifertility effects demonstrated in animal studies.
- Gastrointestinal: Traditional use for diarrhea, dysentery, antiulcer activity in preclinical models.
- Immune system: Immunomodulatory activity of alkaloidal fractions in preclinical studies.
- Cardiovascular: Cardioprotective effects in isoproterenol-induced cardiac dysfunction models.
7. Dosage Forms and Reported Dosages
Pareira root has historically been prepared and administered in several forms. The following dosages are reported in traditional pharmacopoeial and eclectic medical sources, and in contemporary preclinical research. No standardized clinical dosages for humans have been established in modern peer-reviewed trials.
Historical / Pharmacopoeial Preparations
- Crude root (powder): Dose of 5 to 30 grains as recorded in eclectic materia medica.
- Infusion: Used in infusion; dose from two to four drams.
- Tincture (of bark/root): The tincture of the bark and the fluid extract; the dose of the tincture is from one to ten drops.
- Specific Medicine Pareira (liquid extract): Preparation known as Specific Medicine Pareira; dose 1 to 30 drops.
Preclinical Research Doses
- Diuretic studies (rodents): Low (100 mg/kg), medium (200 mg/kg), and high (400 mg/kg) doses of aqueous extract of roots tested in rat models.
- Anticancer study (mice): Methanol extract administered at 200 and 400 mg/kg body weight for 14 consecutive days.
- Hepatoprotective study (rats): Treatment groups given 100, 200, and 400 mg/kg of hydroalcoholic root extract (CPRE).
There is not enough reliable information to know what an appropriate dose of pareira might be for human use.
8. Safety Considerations and Interactions
Oral Safety of the Herbal Root
When taken by mouth, there is not enough reliable information to know if pareira is safe or what the side effects might be. The alkaloids responsible for the muscle relaxant effect are not absorbed by the digestive tract and have to be administered intravenously; therefore, when taken orally the plant is considered safe for herbal use according to some sources, though this assessment lacks formal toxicological validation.
Only a limited amount of research has been done on the toxicological evaluation of C. pareira; more thorough research is needed.
Pregnancy
Pregnancy is an important concern: it is likely unsafe to use pareira when pregnant. It might start the menstrual period and cause a miscarriage. This risk is pharmacologically consistent with the documented emmenagogue and antifertility properties of the plant demonstrated in animal studies. It is likely unsafe to use pareira when pregnant, as it might start menstruation and cause a miscarriage.
Breastfeeding
There is not enough reliable information to know if pareira is safe to use when breastfeeding; staying on the safe side is advised, and use should be avoided.
Tubocurarine: Route of Administration and Systemic Risk
A fundamental pharmacological safety consideration is the route-dependency of tubocurarine's toxicity. South American natives could eat animals killed with curare without adverse effects because tubocurarine cannot easily cross mucous membranes; tubocurarine is effective only if given parenterally. Despite its therapeutic utility when used parenterally, curare's use is associated with significant neurotoxicological risks, including hypotension, histamine-mediated side effects, and prolonged neuromuscular blockade, necessitating careful clinical management and the availability of reversal agents. These risks apply only to parenteral administration and do not apply to standard oral herbal use.
Adulteration and Botanical Identity
A historically significant safety and quality concern is the widespread adulteration of the commercial drug supply. Much of the commercial drug is not genuine; the chief substitute is the root of a Brazilian menispermaceous plant closely allied to Chondrodendron — this drug is in straighter, brownish pieces, which are not as heavy; the section is much less waxy and exhibits more numerous, narrower zones; it has also a less bitter taste and yields less aqueous extract. Ringer and Brooke (1892) proved that the true Chondrodendron root contained a larger quantity of chemical and extractive principles than do the substitutes.
Overall Evidence Gap
Scientific validation for efficacy in treating conditions such as kidney infections is lacking. The totality of the pharmacological evidence base for pareira as an oral herbal preparation rests almost entirely on preclinical in vitro and animal studies, with no controlled human clinical trials published in the peer-reviewed literature confirming efficacy or establishing safe dosing parameters for any indication. The history of pharmacopoeial listing and traditional use is extensive, but it predates evidence-based standards. The isolated compound d-tubocurarine represents a major scientific legacy of the plant, but is irrelevant to its herbal use context.
References
Go back